Yellox™, The First And Only Twice-Daily Ocular NSAID, Approved By The European Commission Following Positive Opinion From CHMP
CROMA Pharma, GmbH (CROMA), a private global specialty pharmaceutical and surgical company and Bausch + Lomb, the global eye health company, today announced the approval of Yellox ™ (Bromfenac sodium sesquihydrate) by the European commission...